Absci Corporation (ABSI) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Absci Corporation, updated every trading day.
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Price
$11.88
+12.39% today
Market cap
$1.8B
Overall quality
25/100
Kronos AI 30-day
−23.1%
0 of 8 simulated paths end higher
Absci Corporation (ABSI) is a Health Care company in Biotechnology: Commercial Physical & Biological Resarch, worth $1.8B. It trades at $11.88, up 12.39% today. Its overall quality score is 25 out of 100, ranked against the whole US market. 9 analysts' average target of $14.63 implies +23.1% from today's price. Kronos AI's 30-day forecast is −23.1% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $14.63 |
| Low – high | $10.00 – $20.00 |
| Analysts | 9 |
| Upside to average | +23.1% |
Kronos AI 30-day forecast
| Expected close | $8.13 (−23.1%) |
| Likely range | −33.8% … −17.5% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 7 |
| Solvency | 53 |
| Growth | 16 |
| Overall | 25 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Commercial Physical & Biological Resarch
For information only, not investment advice. Prices updated: 2026-10-29.